European Journal of Endocrinology

Papers
(The H4-Index of European Journal of Endocrinology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide co578
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study290
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management169
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock150
Autophagy markers are decreased in bone of osteoporotic patients: a monocentric comparative study126
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment104
Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?78
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study71
Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis64
A larger brown fat volume and lower radiodensity are related to a greater cardiometabolic risk, especially in young men62
Sodium-glucose co-transporter inhibitors in insulin-treated diabetes: a meta-analysis60
Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study60
18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study57
Patients with low IGF-I after curative surgery for Cushing’s syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy53
When selection becomes selection bias53
Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps50
High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies48
Serum diiodotyrosine – a biomarker to differentiate destructive thyroiditis from Graves’ disease45
Primary adrenal insufficiency in patients with CPOX gene mutations43
Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trial41
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy41
GLOBAL ENDOCRINOLOGY: Global perspectives in endocrinology: coverage of iodized salt programs and iodine status in 202040
Genome-wide analysis of thyroid function in Australian adolescents highlights SERPINA7 and NCOA339
Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls39
Transcription factor immunohistochemistry in the diagnosis of pituitary tumours39
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis38
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?37
Bone strain index for fracture risk assessment in older men—the prospective STRAMBO study37
Transcriptional comparison of testicular adrenal rest tumors with fetal and adult tissues37
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis35
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial35
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis34
Metabolic health during a randomized controlled lifestyle intervention in women with PCOS33
Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly33
25-OHD response to vitamin D supplementation in children: effect of dose but not GC haplotype33
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors33
0.057631015777588